secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001193125-23-241475
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharma presents at Cantor Healthcare Conference, slide deck furnished
------------------------------------------------------------------------------

- Chairman and CEO Patrick McEnany and senior management presenting at Cantor Global Healthcare Conference on September 26, 2023.
- Webcast available on company website; replay for 14 days.
- Slide deck attached as Exhibit 99.1; no new financial results or guidance disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523241475/0001193125-23-241475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523241475/d539630d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-241475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer